management

Bronchiectasis is a chronic, debilitating respiratory condition that affects people of all ages. It is most prevalent in women and those older than 60 years, and prevalence is increasing. Patients have daily excessive sputum and associated symptoms, recurrent chest infections and impaired health-related quality of life. In North America, management guidelines are lacking. This review discusses best evidence to guide the long-term management of non–cystic fibrosis bronchiectasis in adults, focusing on the two most common single-entity types of bronchiectasis in adults: idiopathic and postinfectious bronchiectasis (Box 1). Table 1 lists all the types of bronchiectasis by cause.

Author/s:

Maeve P. Smith

2020 Focused Updates to the Asthma Management Guidelines: At-a-Glance Guide

Aubrey Delammermore — Wed, 12 Apr 2023 05:00:00 +0000

Date Added:

April 12, 2023

Journal/Publication:

NIH Publication No. 20-HL-8142

Publisher:

US Department of Health and Human Services

Publication Date:

December 1, 2020

URL:

2020 Focused Updates to the Asthma Management Guidelines: At-a-Glance Guide

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

Keywords

MeSH

Patient Care Management

asthma

Judgment

Anti-Asthmatic Agents

A concise summary of the 2020 NIH Guidelines for management of asthma. James W. Mold, MD, MPH

Free full text

View

This At-A-Glance Guide describes a treatment management approach based on recommendations from the 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Step diagrams from the 2007 Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3) were updated with the new recommendations. The diagrams are intended to help clinicians integrate the new recommendations into clinical care, and are meant to assist, and not replace, clinical judgment or decision-making for individual patient
management, with input from individuals with asthma about their preferences

Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations

Aubrey Delammermore — Sat, 07 Jan 2023 06:00:00 +0000

Date Added:

January 7, 2023

Journal/Publication:

Journal of Family Medicine and Primary Care

Publisher:

Wolters Kluwer

Publication Date:

November 1, 2022

Issue:

Volume:

Pages:

6633-6639

URL:

Management of chronic respiratory diseases during viral pandemics: A concise review of guidance and recommendations

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

DOI (1):

10.4103/jfmpc.jfmpc_974_21

Keywords

asthma

interstitial lung disease

MeSH

Respiration Disorders

pulmonary disease, chronic obstructive

COVID-19

Respiratory Insufficiency

Important evidence-based strategies for reducing morbidity and mortality from acute respiratory infections in patients with chronic lung diseases. James W. Mold MD, MPH

Free full text

View

Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute respiratory disease that can lead to respiratory failure and death. Although anticipated that patients with chronic respiratory diseases would be at increased risk of SARS-CoV-2 infection and more severe presentations of COVID-19, it is striking that these diseases appear to be underrepresented in the comorbidities reported for patients with COVID-19. The first wave of COVID-19 has taught us important lessons concerning the enormous burden on the hospitals, shortage of beds, cross infections and transmissions, which we coped together. However, with the subsequent waves of COVID-19 or any other viral pandemic, to ensure that patients with respiratory illnesses receive adequate management for their diseases while minimizing their hospital visits for their own safety. Hence, we prepared an evidence-based summary to manage outpatients and inpatients suspected or diagnosed with COPD, asthma and ILD based on the experience of the first wave of COVID-19 and recommendations by expert societies and organizations.

Author/s:

Sharma, P., Mishra, M., Dua, R., Saini, L. K., Sindhwani, G.

Diagnosis and Management of Hereditary Hemochromatosis

Aubrey Delammermore — Sat, 12 Nov 2022 06:00:00 +0000

Date Added:

November 12, 2022

Journal/Publication:

JAMA

Publisher:

Massachusetts Medical Society

Publication Date:

November 8, 2022

Issue:

Volume:

328

Pages:

1862-1863

URL:

Diagnosis and Management of Hereditary Hemochromatosis

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

DOI (1):

10.1001/jama.2022.17727

Keywords

Hemochromatosis Protein

diagnosis

Hereditary hemochromatosis

management

diagnosis and management

PMID (1):

36346422

MeSH

liver

Hemochromatosis* / diagnosis

Hemochromatosis* / genetics

Hemochromatosis* / therapy

Hemochromatosis Protein

A updated summary of the pathophysiology, diagnosis, and treatment of hemochromatosis. James W. Mold, MD, MPH

Free full text

View

Hereditary hemochromatosis (HH) is a heterogeneous genetic disorder that results in unregulated and excessive intestinal iron absorption leading to overabundance of iron deposition in tissue. HH is most common in people of northern European ancestry, for whom the prevalence is 1 case per 300 people.1-3

Author/s:

Cabrera, E., Crespo, G., VanWagner, L.B.

Diagnosis and management of postural orthostatic tachycardia syndrome

Saige Blanchard — Thu, 10 Mar 2022 06:00:00 +0000

Date Added:

March 22, 2022

Journal/Publication:

Canadian Medical Association Journal

Publisher:

Canadian Medical Association

Publication Date:

March 14, 2022

Issue:

Volume:

194

Pages:

E378-E385

URL:

Diagnosis and management of postural orthostatic tachycardia syndrome

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

DOI (1):

https://doi.org/10.1503/cmaj.211373

Keywords

POTS

diagnosis

management

Postural Orthostatic Tachycardia Syndrome

PMID (1):

35288409

MeSH

female

Adult

quality of life

Postural Orthostatic Tachycardia Syndrome

Orthostatic Intolerance

A concise review of the diagnosis and management of Postural Orthostatic Tachycardia Syndrome (POTS). James W. Mold, MD, MPH

Free full text

View

Postural orthostatic tachycardia syndrome (POTS) is a chronic multisystem disorder; the cardinal feature is orthostatic tachycardia.

Patients with POTS have symptoms of orthostatic intolerance that improve with recumbence.

Girls and women are more commonly affected with POTS, beginning in puberty and through early adulthood.

Postural orthostatic tachycardia syndrome can lead to marked functional disability, often limiting work or schooling.

Treatments for POTS can improve symptoms and function, and can be initiated in primary care.

The main characteristic of postural orthostatic tachycardia syndrome (POTS) is tachycardia when standing, without a drop in blood pressure. Patients describe lightheadedness and palpitations when upright, particularly when standing, which sometimes leads to syncope. Patients may experience impaired quality of life and functional disability, which can be economically devastating.1–3 The syndrome is more common in girls and young women and has been associated with other disorders, like migraine and Ehlers–Danlos syndrome.4 We discuss the diagnosis of POTS, conditions to consider in the differential diagnosis, associated disorders and the pharmacologic and nonpharmacologic management of patients with POTS, based on original research, narrative reviews and consensus statements

Author/s:

Raj, S. R., Fedorowski, A., Sheldon, R. S.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management

Saige Blanchard — Mon, 03 Jan 2022 06:00:00 +0000

Date Added:

January 3, 2022

Journal/Publication:

Mayo Clinic Proceedings

Publisher:

Elsevier

Publication Date:

August 25, 2021

Issue:

Volume:

Pages:

2861-2878

URL:

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management

Format:

Article

DOI (1):

10.1016/j.mayocp.2021.07.004

Keywords

Myalgic Encephalomyelitis

Chronic Fatigue Syndrome

diagnosis

management

PMID (1):

34454716

MeSH

Humans

fatigue syndrome, chronic

quality of life

COVID-19

National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division

RPR Commentary: A nice review of the diagnosis and management of patients with chronic fatigue syndrome. James W. Mold, MD, MPH

Free full text

View

Despite myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affecting millions of people worldwide, many clinicians lack the knowledge to appropriately diagnose or manage ME/CFS. Unfortunately, clinical guidance has been scarce, obsolete, or potentially harmful. Consequently, up to 91% of patients in the United States remain undiagnosed, and those diagnosed often receive inappropriate treatment. These problems are of increasing importance because after acute COVID-19, a significant percentage of people remain ill for many months with an illness similar to ME/CFS. In 2015, the US National Academy of Medicine published new evidence-based clinical diagnostic criteria that have been adopted by the US Centers for Disease Control and Prevention. Furthermore, the United States and other governments as well as major health care organizations have recently withdrawn graded exercise and cognitive-behavioral therapy as the treatment of choice for patients with ME/CFS. Recently, 21 clinicians specializing in ME/CFS convened to discuss best clinical practices for adults affected by ME/CFS. This article summarizes their top recommendations for generalist and specialist health care providers based on recent scientific progress and decades of clinical experience. There are many steps that clinicians can take to improve the health, function, and quality of life of those with ME/CFS, including those in whom ME/CFS develops after COVID-19. Patients with a lingering illness that follows acute COVID-19 who do not fully meet criteria for ME/CFS may also benefit from these approaches.

Author/s:

Bateman, L., Bested, A., Bonilla, H., Chheda, B., Chu, L,, Curtin, J. M., Dempsey, T. T., Dimmock, M. E., Dowell, T. G., Felsenstein, D., Kaufman, D. L., Klimas, N. G., Komaroff, A. L., Lapp, C. W., Levine, S. M., Montoya, J. G., Natelson, B. H., Peterson, D. L., Podell, R. N., Rey, I. R., Ruhoy, I. S., Vera-Nunez, M. A., Yellman, B. P.

A 61-year-old Woman With Chronic Leg Lymphedema Managed With Complete Decongestive Therapy

Brian Desmarais — Fri, 03 Jul 2020 19:18:53 +0000

Date Added:

July 3, 2020

Journal/Publication:

Canadian medical Association Journal

Publication Date:

June 29, 2020

Issue:

Volume:

192

Pages:

E708-E712

URL:

A 61-year-old Woman With Chronic Leg Lymphedema Managed With Complete Decongestive Therapy

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

DOI (1):

10.1503/cmaj.190227.

Keywords

chronic lower extremity lymphedema

MeSH

A case-based review of the diagnosis and management of chronic lower extremity lymphedema. James W. Mold, MD, MPH

Free full text

View

Not available.

Author/s:

Bondalevich, L., Laplante, S.

Hepatitis B Management: Guidance for the Primary Care Provider

John Bayhi — Fri, 10 Apr 2020 14:22:26 +0000

Date Added:

April 10, 2020

Publisher:

Hepatitis B Online

Publication Date:

February 25, 2020

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

Keywords

A very useful guide to the diagnosis and treatment of hepatitis B infections from AAFP. James W. Mold, MD, MPH

Free full text

View

The purpose of this document is to provide simplified, up-to-date, and readily accessible guidance for primary care medical providers related to the prevention, diagnosis, and management of hepatitis B virus (HBV) infection, including hepatocellular carcinoma surveillance.

Author/s:

Tang, AS, Thornton, K, HBV Primary Care Working Group